IRIS
RIA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.344
EU - Europa 2.145
AS - Asia 825
AF - Africa 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 13.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.341
SE - Svezia 773
CN - Cina 670
IT - Italia 346
DE - Germania 262
UA - Ucraina 253
FI - Finlandia 167
GB - Regno Unito 157
FR - Francia 65
BE - Belgio 51
IN - India 49
VN - Vietnam 40
IE - Irlanda 37
HK - Hong Kong 23
JP - Giappone 19
PL - Polonia 7
RU - Federazione Russa 7
IR - Iran 6
NL - Olanda 5
EG - Egitto 4
KR - Corea 4
AU - Australia 3
CA - Canada 3
ES - Italia 3
TR - Turchia 3
TW - Taiwan 3
CH - Svizzera 2
CL - Cile 2
EU - Europa 2
HU - Ungheria 2
MK - Macedonia 2
TH - Thailandia 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
IL - Israele 1
IQ - Iraq 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MW - Malawi 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.327
Salva come PNG Salva come JPEG
Città #
Fairfield 1.532
Chandler 1.152
Woodbridge 1.066
Ashburn 756
Houston 660
Seattle 630
Nyköping 597
Jacksonville 581
Cambridge 559
Wilmington 501
Ann Arbor 481
Lawrence 211
Roxbury 208
New York 207
Nanjing 203
Beijing 151
Bari 130
Des Moines 130
Inglewood 111
Princeton 105
San Diego 62
Nanchang 57
Boardman 56
Brussels 51
Shenyang 51
Brooklyn 42
Dearborn 42
Dong Ket 40
Dublin 37
Jiaxing 33
Rome 32
Hebei 31
London 29
Leawood 27
Helsinki 26
Los Angeles 26
Pune 26
Marseille 25
Tianjin 25
Washington 23
Grafing 20
Changsha 18
Osaka 16
Paris 16
Augusta 15
Redwood City 15
Kunming 14
Zhengzhou 14
Jinan 13
Falls Church 12
Florence 10
Guangzhou 10
San Mateo 8
Taizhou 8
Kilburn 7
Monmouth Junction 7
Ardabil 6
Hefei 6
Milan 6
Mumbai 6
Ningbo 6
Tappahannock 6
Islington 5
Norwalk 5
Nürnberg 5
Acton 4
Alcamo 4
Aragona 4
Auburn Hills 4
Chicago 4
Chiswick 4
Hounslow 4
Messina 4
Parma 4
Prescot 4
Radomsko 4
Bengaluru 3
Cutrofiano 3
Detroit 3
Hong Kong 3
Istanbul 3
New Bedfont 3
New Delhi 3
Obrigheim 3
Suri 3
Verona 3
Adelfia 2
Baotou 2
Bitetto 2
Budapest 2
Candiolo 2
Castellammare di Stabia 2
Chiang Mai 2
Corsico 2
Costa Mesa 2
Edinburgh 2
Fano 2
Fragagnano 2
Fuzhou 2
Groningen 2
Totale 11.068
Salva come PNG Salva come JPEG
Nome #
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 213
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 132
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 126
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 125
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 115
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 111
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 110
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 109
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 107
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 107
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 107
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 106
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 105
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 105
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 104
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 103
Identify multiple myeloma stem cells: Utopia? 103
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials 103
null 101
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 99
Recurrent primary plasmacytoma of the eyelid with rapid regional metastasis 98
Neutropenia and G-CSF in lymphoproliferative diseases 97
Delayed complete remission in a patient with multiple myeloma 96
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 96
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 96
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 96
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 95
Fibrinogen apheresis in the treatment of peripheral arterial disease 94
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 94
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 93
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 93
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 93
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis 92
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 91
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts 90
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 90
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 90
null 88
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial 88
Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? 88
null 87
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma 87
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression 86
Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials 86
Angiogenesis in multiple myeloma 85
Circulating miRNA markers show promise as new prognosticators for multiple myeloma 85
Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers? 84
Could multiple myeloma VEGF modify the systemic microcirculation? 83
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial 79
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response 79
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 78
Endothelial cells in the bone marrow of patients with multiple myeloma 77
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 77
Efficacy and safety of once weekly bortezomib in multiple myeloma patients 77
Circulating cell adhesion molecules are increased in hypertensive left ventricular hypertrophy 76
null 76
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 76
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis 76
null 75
TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically 75
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis 75
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 75
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 75
Human recombinant interferon alpha-2a inhibits angiogenesis of chick area vasculosa in shell-less culture 74
Angiogenesis and progression in human melanoma 74
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 74
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone(VMP) in untreated multiple myeloma patients with renal impairment. 74
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients 73
Cross-talk between hematopoiesis and angiogenesis signaling pathways 73
Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia 72
In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane 72
Development of vasculature targeting strategies for the treatment of chronic inflammatory diseases 71
null 71
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 71
Monoclonal gammopathy as a marker of primary cerebral lymphoma 70
Cancer-related coagulopathy (Trousseau's syndrome): Review of the literature and experience of a single center of internal medicine 70
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin’s lymphomas 70
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis 70
Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women 68
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma 68
Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane 68
Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study 68
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 68
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma 68
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 67
Mast cell contribution to angiogenesis related to tumour progression 67
Role of angiogenesis and microenvironment in melanoma progression 67
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study) 67
null 67
Angiogenesi midollare e molecole di adesione per l’endotelio nei pazienti con mieloma multiplo (MM) e con gammapatia monoclonale non mielomatosa (MGUS) 66
Role of stromal cells in neovascularization of multiple myeloma 66
null 66
Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma 66
Bortezomib treatment modulates autophagy in multiple myeloma 66
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 66
Effects of severe hypertension on soluble cellular adhesion molecule levels 65
Angiogenesi e progressione tumorale nel melanoma 64
Angiogenesis in Chronic Lymphocytic Leucemia: an emerging target 64
null 63
A weekly infusion of bortezomib reduces peripheral neuropathy 63
Totale 8.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019809 0 0 0 0 0 0 0 0 0 0 388 421
2019/20203.531 547 181 107 287 360 252 369 352 478 200 272 126
2020/20212.564 175 157 183 151 370 190 205 200 182 335 243 173
2021/20221.615 147 202 17 52 63 102 92 83 92 120 269 376
2022/20232.897 377 301 184 283 337 422 21 307 530 22 56 57
2023/20241.018 99 195 70 60 104 323 60 75 7 22 3 0
Totale 13.882